Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other financing activities (2018 - 2025)

Historic Other financing activities for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q2 2025 value amounting to $803000.0.

  • Whitehawk Therapeutics' Other financing activities rose 1137142.86% to $803000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 1092745.1%. This contributed to the annual value of $16000.0 for FY2024, which is 9000.0% down from last year.
  • According to the latest figures from Q2 2025, Whitehawk Therapeutics' Other financing activities is $803000.0, which was up 1137142.86% from $4.8 million recorded in Q1 2025.
  • Over the past 5 years, Whitehawk Therapeutics' Other financing activities peaked at $9.6 million during Q3 2021, and registered a low of -$1000.0 during Q4 2024.
  • Over the past 5 years, Whitehawk Therapeutics' median Other financing activities value was $63000.0 (recorded in 2023), while the average stood at $1.6 million.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Other financing activities plummeted by 10294.12% in 2024, and later soared by 4812000.0% in 2025.
  • Quarter analysis of 5 years shows Whitehawk Therapeutics' Other financing activities stood at $9.6 million in 2021, then plummeted by 98.81% to $114000.0 in 2022, then plummeted by 70.18% to $34000.0 in 2023, then crashed by 102.94% to -$1000.0 in 2024, then soared by 80400.0% to $803000.0 in 2025.
  • Its last three reported values are $803000.0 in Q2 2025, $4.8 million for Q1 2025, and -$1000.0 during Q4 2024.